We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App


24 Feb 2024 - 28 Feb 2024
05 Mar 2024 - 07 Mar 2024

Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour

By LabMedica International staff writers
Posted on 09 Aug 2023
Print article
Image: The FDA has cleared the Alinity h-series lab instruments, enabling advanced testing of patients’ CBCs (Photo courtesy of Abbott)
Image: The FDA has cleared the Alinity h-series lab instruments, enabling advanced testing of patients’ CBCs (Photo courtesy of Abbott)

Complete blood counts (CBCs) are frequently requested in healthcare for screening various disorders like infections, anemia, immune system diseases, and blood cancers. Now, the U.S. Food and Drug Administration's (FDA) clearance for an advanced hematology system paves the way for laboratories throughout the U.S. to run CBCs in the most efficient manner possible.

Abbott (Lake Forest, IL, USA) has secured U.S. FDA approval for its state-of-the-art Alinity h-series hematology system. This system can seamlessly integrate into the existing Alinity lab systems set up across the U.S., enhancing the capabilities of these laboratories. As a result, hospitals can more readily execute CBCs, which are among the top-requested tests for patients. The Alinity h-series system offers several advantages for laboratories including the ability to process up to 119 CBC results per hour which is among the fastest on the market and the requirement for less floor space, which is critical for labs to maximize resources and operations.

The Alinity h-series boasts of the Alinity hq, an automated blood analyzer, and the Alinity hs, a combined slide creator and stainer. A standout feature of the Alinity hq is its innovative MAPS™ technology that utilizes light scattering to distinguish cellular features and better recognize different blood cells. With the Alinity h-series, Abbott now offers one of the broadest laboratory diagnostic systems, offering an extensive range of tests for timely and efficient patient care. U.S. labs and hospitals will find it easy to incorporate the Alinity h-series hematology system into their primary operations with minimal effort and training for their staff. This ease of integration is crucial for labs grappling with time and resource constraints. In the U.S., the Alinity portfolio now spans the Alinity h-series (hematology), Alinity ci (clinical chemistry and immunoassay), Alinity m (molecular), Alinity s (transfusion), and the point-of-care i-STAT Alinity.

“U.S. healthcare systems have experienced significant resource constraints and rapidly shifting dynamics post-pandemic,” said Louis Morrone, executive vice president for Abbott’s core diagnostics business. “The Alinity h-series system, as with the entire suite of Alinity products, was developed to transform the way laboratories run tests so they can focus on their most important mission: the delivery of patient care.”

Related Links:

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article


Clinical Chemistry

view channel
Image: Wireless Point-of-Care Testing for Hepatitis B Virus (Photo courtesy of Chulalongkorn University)

Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step

Hepatitis B, a significant global health concern, is responsible for chronic liver diseases like cirrhosis and liver cancer which is one of the most common cancers worldwide. The challenge with hepatitis... Read more

Molecular Diagnostics

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disorder that typically presents as venous or arterial thrombosis and/or pregnancy loss. Diagnosing APS can be difficult as its symptoms often resemble... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.